QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening

Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023

Related Keywords

Indonesia ,Netherlands ,Venlo ,Limburg ,Universitas Padjadjaran ,Jawa Barat ,Frankfurt ,Brandenburg ,Germany ,John Gilardi ,Davide Manissero ,Phoebe Loh ,Thomas Theuringer ,Daniela Eltrop ,Exchange Commission ,Globenewswire Inc ,World Health Organization ,Laboratory Medicine ,Us Securities Exchange ,Frankfurt Prime Standard ,Clinical Chemistry ,Health Organization ,Chief Medical Officer ,Applied Testing ,Exchange Act ,Annual Report ,Qiagennv Stock Exchange ,News ,Information ,Press Release ,The ,Pune ,023 ,Iagen ,Elcomes ,Publication ,F ,Ystematic ,Review ,Ighlighting ,Unique ,Value ,Its ,Roprietary ,Tuberculosis ,Testing ,He Qgen Nl0012169213 ,